Equus Total Return Receives NYSE Non-Compliance Notice Over Share Price
Equus Total Return, Inc. (EQS) has received a non-compliance notice from the New York Stock Exchange after failing to meet minimum price requirements. The deficiency occurred because the company's stock maintained an average closing price below $1.00 over a consecutive 30-day trading period. Shares of the company closed down 4.49% at $0.84.
The notice raises long-term delisting risks if the stock fails to recover, though trading in the shares remains active on the NYSE without immediate disruption. Equus Total Return has been granted a six-month cure period to bring its average closing price back above the $1.00 threshold.
To resolve the non-compliance, the company is evaluating strategic options, which may include implementing a reverse stock split. Investors will be watching for official announcements regarding its compliance plan and any corporate actions taken before the six-month deadline expires.
Key points
- Equus Total Return, Inc. received an NYSE notice for failing to maintain a $1.00 average closing price over 30 days.
- The company's stock fell 4.49% to close at $0.84 per share.
- Equus Total Return has a six-month window to regain compliance with NYSE listing standard requirements.
- Listing and trading of the company's shares remain active on the NYSE without immediate disruption.
- The company is considering a reverse stock split as a possible remedy to elevate its share price.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
Why did Equus Total Return receive a notice from the NYSE?
Equus Total Return received an NYSE non-compliance notice because its stock failed to maintain an average closing price of at least $1.00 over a 30-day period.
Is Equus Total Return stock being delisted immediately?
No, trading remains unaffected for now. The company has been given a six-month cure period to regain compliance with NYSE requirements.
How does Equus Total Return plan to fix its NYSE price compliance issue?
The company plans to address the deficiency within the six-month deadline and is considering a reverse stock split to raise its share price above $1.00.